Zydus Lifesciences Limited — Updates, 24-09-2025: General Updates
24-09-2025 | 10:30 am
24-09-2025 | 10:30 am
Zydus Lifesciences declared an ₹11 dividend at its AGM, showcasing strong growth and enhanced EPS. Key strategic moves include MedTech entry, innovation in biologics/vaccines, and AI integration. Management addressed USFDA observations at its Oncology plant, expecting no significant impact, and clarified strategic investments in various subsidiaries.
No comments yet. Be the first to comment!
